CASE Op-Ed in DC Journal: The Biden-Harris IRA Anniversary Is Nothing To Celebrate
Two years after President Joe Biden signed the Inflation Reduction Act (IRA) into law, the grim reality of its...
CASE Statement on the Disastrous, Anti-Senior Biden-Harris IRA Legislation
The Biden-Harris administration held a campaign event for the media today to claim that their Inflation Reduction Act (IRA) legislation has...
Biden Claims Victory as Medical Innovation is Threatened
October 4, 2023 President Biden announced yesterday that the makers of the first 10 drugs selected for so-called Medicare...
The Small Molecule Penalty Mindlessly Pulls the Brake on Medical Innovation
September 13, 2023 (Alexandria, Virginia) — Today Consumer Action for a Strong Economy (CASE), urged the House Committee on...
One Year In, the Inflation Reduction Act Continues to Fail American Consumers
August 16, 2023 One year ago today, President Biden signed the Inflation Reduction Act into law. Gerard Scimeca, Chairman...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/